Like I previously told you, it's dependent on the release of the clinical trial updates. So CVI can only convert the accrued $2M 6 monthly worth which hasn't previously been converted to a max of $20M so why would they convert if further positive clinical trial update is released during the 6 months???? If they push the pps to 1.9c and there hasn't been any clinical trial updates then I would be buying more.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)